Search

Displaying results 9971 - 9980 of 10000 in total
  1. Drug

    N-6022

    go.drugbank.com/drugs/DB12206
    Investigational

    N6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.

  2. Drug

    LY-2608204

    go.drugbank.com/drugs/DB12284
    Investigational

    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

  3. Drug

    Evocalcet

    go.drugbank.com/drugs/DB12388
    Investigational

    Evocalcet has been used in trials studying the treatment of Hyperparathyroidism and Secondary Hyperparathyroidism.

  4. Drug

    MK-3207

    go.drugbank.com/drugs/DB12424
    Investigational

    Mk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders.

  5. Drug

    Netivudine

    go.drugbank.com/drugs/DB12606
    Investigational

    Netivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.

  6. Drug

    GSK-690693

    go.drugbank.com/drugs/DB12745
    Investigational

    GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.

  7. Drug

    Batefenterol

    go.drugbank.com/drugs/DB12526
    Investigational

    Batefenterol has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  8. Drug

    Ohmefentanyl

    go.drugbank.com/drugs/DB01570
    ExperimentalIllicit

    Researchers are studying the different pharmaceutical properties of these isomers. … Ohmefentanyl is one of the most potent μ -receptor agonists known, comparable to super-potent opioids such as carfentanil and etorphine which are used for tranquilizing large animals such as elephants

  9. Drug

    Nivatrotamab

    go.drugbank.com/drugs/DB16654
    Investigational

    Nivatrotamab is under investigation in clinical trial NCT03860207 (Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3f8-bsab) in Patients With Relapsed/refractory Neuroblastoma,

  10. Drug

    Licaminlimab

    go.drugbank.com/drugs/DB18936
    Investigational

    Licaminlimab is under investigation in clinical trial NCT05896670 (Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease).